位置:首页 > 产品库 > Concanavalin A
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Concanavalin A
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
规格:98%
分子量:N/A
包装与价格:
包装价格(元)
50mg询价
100mg询价
250mg询价

刀豆球蛋白 A 是一种 Ca2+/Mn2+- 依赖和甘露糖/葡萄糖结合的植物凝集素,可以在长豆中找到。
货号:ajcx11536
CAS:11028-71-0
分子式:N/A
分子量:N/A
溶解度:Soluble in water
纯度:98%
存储:Store at -20°C
库存:现货

Background:

Concanamycin A belongs to the concanamycins, a family of macrolide antibiotics isolated from Streptomyces diastatochromogenes that are highly active and selective inhibitors of the vacuolar proton-ATPase (v-[H[+]]ATPase). Among them, concanamycin A is the most selective and potent inhibitor of the V-[H[+]]ATPase.[1]

n vitro study indicated that concanamycin A was active at 5 nM and completely blocked influenza virus infection at 10 nM in MDCK cells. Results showed that concanamycin A blocked viral replication by inhibiting the v-[H[+]]ATPase, thus preventing acidification of endosomes and release of virions into the cytoplasm. An early event in virus infection is the target of concanamytin A. In addition, the inhibition of the v-[H[+]]ATPase by concanamycin A prevents endosomal acidification, inhibiting virus release from endosomes.[1]

参考文献:
[1].Rosario G. et al. Concanamycin A blocks influenza virus entry into cells under acidic conditions. FEBS Letters 1994 June; 349; 327-330.

Protocol:

Cell experiment [1]:

Cell lines

CD8+ CTL

Preparation Method

Cells were cultured in the RPMI 1640 medium supplemented with 10% (v/v) FCS and 5% (v/v) culture supernatant of rat spleen cells.

Reaction Conditions

Cells were stimulated with 5 μg/ml of concanavalin A for 24 h.

Applications

Concanavalin A treatment could preferentially decrease the cell viability of CD8+ population prepared from the immunized mice. A certain group(s) of CD8+ population in the immunized mice might be highly susceptible to concanavalin A. The activation through T cell receptors, especially PKC activation, increases the sensitivity of CD8++ CTL to concanavalin A.

参考文献:

[1]. Kenichi T. et al. Concanamycin A, a vacuolar type H+-ATPase inhibitor, induces cell death in activated CD8+ CTL. Cytotechnology 1997 July; 25: 127–135.

 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024